Cortechs.ai | Cortechs.ai and Hitachi announce support of Hitachi MRI scanners for NeuroQuant®

Cortechs.ai and Hitachi announce support of Hitachi MRI scanners for NeuroQuant®

Increased Physician Access to Volumetric MRI Processing with Additional Scanner Options, Including Open MRIs

(SAN DIEGO) – Cortechs.ai, the leading medical software innovator providing solutions for quantitative brain volume analysis, is pleased to announce that Hitachi 1.2T Oasis, 1.5T Echelon Oval and 3.0T Trillium Oval MRI scanners are compatible with NeuroQuant®, the foremost medical device software for volumetric MRI processing. Cortechs.ai and Hitachi worked together to validate the 1.2T, 1.5T and 3.0T Hitachi MRI scanners, ensuring accurate and consistent brain segmentation results for Hitachi MRI customers.

This capability provides neuroradiologists in hospitals, clinics, imaging and research centers worldwide with expanded MRI scanner options when using Cortechs.ai automated brain image analysis software solutions in the assessment of neurodegeneration disorders, such as Alzheimer’s disease, epilepsy, multiple sclerosis, as well as, brain volume changes caused by brain trauma.

Cortechs.ai’ fast, accurate, reproducible, and proven quantitative imaging solution is the first FDA cleared and CE marked software that provides radiologists and neurologists with quantifiable, volumetric data to help in the assessment of brain atrophy and lesion evolution.

“This Hitachi scanner validation marks the first time that NeuroQuant products can be used with open MRI scanners, helping to accommodate a broader patient demographic for neurodegenerative evaluations,” said Guri Stark, Cortechs.ai’ CEO. “We are excited to include Hitachi 1.2T, 1.5T and 3.0T MRI scanners as options for NeuroQuant analysis, thereby strengthening our goal of providing a vendor neutral product, allowing physicians and clinicians more freedom in MRI scanner choices.”

“We are always looking to provide our customers with enhanced and expanded imaging capabilities,” said Sheldon Schaffer, Vice President and General Manager, MR/CT, Hitachi Healthcare Americas. “With NeuroQuant products now validated and compatible with Hitachi 1.2T Oasis, 1.5T Echelon Oval and 3.0T Trillium Oval MRI scanners, healthcare providers have access to exceptional automated brain volume imaging technology, allowing them to deliver better patient care in Hitachi’s unique patient-centric environment.”

ABOUT CORTECHS LABS
Cortechs.ai develops and markets breakthrough medical device software solutions capable of automatically segmenting and quantifying brain structures, making quantitative analysis of the human brain a routine part of clinical practice. Cortechs.ai’ cutting-edge brain imaging analysis provides neurologists, radiologists, and clinical researchers worldwide with a convenient and cost-effective means to quantify subcortical structures to help assess a variety of neurological conditions, such as Alzheimer’s disease, epilepsy, multiple sclerosis, brain trauma and brain development. Please visit cortechs.ai for further information.

ABOUT HITACHI HEALTHCARE AMERICAS
Hitachi Healthcare Americas, located in Twinsburg, Ohio, a wholly owned subsidiary of Hitachi Healthcare Business Unit, offers a broad range of diagnostic imaging equipment including MRI, CT and Ultrasound. Hitachi’s MRI, CT and Ultrasound technologies provide speed, comfort and quality for both physicians and patients alike and play an important role in the diagnosis and treatment of disease while driving social innovation into healthcare. Visit www.hitachihealthcare.com.

ABOUT HITACHI, LTD.
Hitachi, Ltd. (TSE: 6501), headquartered in Tokyo, Japan, delivers innovations that answer society’s challenges. The company’s consolidated revenues for fiscal 2016 (ended March 31, 2017) totaled 9,162.2 billion yen ($81.8 billion). The Hitachi Group is a global leader in the Social Innovation Business, and it has approximately 304,000 employees worldwide. Through collaborative creation, Hitachi is providing solutions to customers in a broad range of sectors, including Power / Energy, Industry / Distribution / Water, Urban Development, and Finance / Government & Public / Healthcare. For more information on Hitachi, please visit the company’s website at www.hitachi.com

More Resources

09/03/2025

Reimbursement Considerations for OnQ Prostate and Category III CPT Codes 0648T & 0649T

Learn how Cat. III CPT codes 0648T and 0649T apply to OnQ™ Prostate, offering guidance for accurate reporting, reimbursement, and building evidence for coverage

09/02/2025

Maximizing the Value of Prostate MRI for the Urologist

Even with expert radiologists or AI models at hand, the challenge remains: how can urologists improve seeing and interpreting cancer?

08/18/2025

Why Bigger Normative Databases Mean Better Brain Imaging

NeuroQuant® 5.2 compares patient brain MRI volumes to over 7,000 healthy scans, giving clinicians clear, percentile-based context for better assessments.

08/07/2025

Navigating Reimbursement for NeuroQuant: Understanding CPT Codes 0865T & 0866T 

Let’s break down the latest category III CPT codes and example clinical use cases that illustrate their value.

07/31/2025

Precision Without the Pressure: Smarter Brain Tumor Monitoring

Learn about NeuroQuant Brain Tumor 2.0 and how it assists clinicians by providing objective quantification and analysis of tumor changes over time.

07/30/2025

Cortechs.ai Announce Next-Gen NeuroQuant Brain Tumor: AI-Driven Metastasis & Meningioma Segmentation 

NeuroQuant Brain Tumor is the first FDA-cleared, cloud-native tool to offer automated volumetric segmentation for brain metastases, meningiomas, and gliomas.
Scroll to Top